Volume 11, Issue 2 (6-2008)                   J Arak Uni Med Sci 2008, 11(2): 35-41 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Darreh F, Kahbazi M. Comparing the effect of intermittent Diazepam and continuous Phenobarbital in prophylaxis of recurrence of febrile seizure. J Arak Uni Med Sci 2008; 11 (2) :35-41
URL: http://jams.arakmu.ac.ir/article-1-217-en.html
1- , fatemeh _ dorre @ yahoo.com
Abstract:   (19529 Views)
Introduction: The vast majority of children with febrile seizure have a normal long term out come, but their parents are always worrying about recurrent febrile seizure. With attention to controversy in treatment a precise knowledge of the short and long term side effect is an important prerequisite for assessing the various treatment strategies. In this study we evaluated the efficacy of intermittent Diazepam and continuous Phenobarbital for the prophylaxis of recurrence of febrile seizure. Materials and Methods: In this clinical trial study 100 children with febrile seizure treated with intermittent Diazepam were compared with 100 children with febrile seizure treated with continuous Phenobarbital. Diazepam (1 mg/kg/d) was administered orally every eight hours during all febrile illness and Phenobarbital (3-5 mg/kg/d) was administered daily. Data were analyzed by chi-square and t-test. Results: During a mean follow up of 19 months, recurrence rates in the two groups were similar (14%). 74% of children receiving Phenobarbital had side effects versus 26% receiving Diazepam. (p=0.00001). Mean of fever in year was 3.2 ± 1.4 in Phenobarbital group and 3.0 ± 1.1 in which had no significant difference. Conclusion: Oral Diazepam, given only when fever is present, is safe and reduces the risk of recurrent febrile seizure.
Full-Text [PDF 185 kb]   (9670 Downloads)    
Subject: General
Received: 2009/03/5

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Arak University of Medical Sciences

Designed & Developed by : Yektaweb